Congress Looks at Pediatric Incentives in BPCA, PREA Talks
By Mari Serebrov
Friday, February 3, 2012
While the reauthorization of PDUFA was the focal point of a House subcommittee hearing Wednesday, lawmakers also began consideration of two acts that require and incentivize pediatric drug trials.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.